Oncology & Hematology Coding Alert

Here's Why Simultaneous Infusions Don't Always Equal 'Concurrent' Code

Learn 2 key lessons about when to keep +96368 off of your claim. If you've got questions about concurrent infusion code +96368, you certainly aren't alone. But we've got answers to help put the confusion behind you. We'll consider two infusion sessions and reveal how one small difference -- the number of bags -- can affect your coding. Scenario 1: Decide on Codes for Single Bag Infusion Suppose your chart shows the following service: The Aloxi (an anti-emetic) and Dex (an anti-inflammatory steroid) were in the same bag. You must determine whether to use concurrent infusion code +96368 (Intravenous infusion, for therapy, prophylaxis, or diagnosis [specify substance or drug]; concurrent infusion [List separately in addition to code for primary procedure]) when reporting the codes for this session. Not so fast: You should not report +96368 for this session. To use the concurrent infusion code, the simultaneously administered drugs must be in separate [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All